JP2013545785A5 - - Google Patents

Download PDF

Info

Publication number
JP2013545785A5
JP2013545785A5 JP2013543799A JP2013543799A JP2013545785A5 JP 2013545785 A5 JP2013545785 A5 JP 2013545785A5 JP 2013543799 A JP2013543799 A JP 2013543799A JP 2013543799 A JP2013543799 A JP 2013543799A JP 2013545785 A5 JP2013545785 A5 JP 2013545785A5
Authority
JP
Japan
Prior art keywords
compound according
compound
motomeko
group
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013543799A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013545785A (ja
JP6005656B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2011/073008 external-priority patent/WO2012080446A1/en
Publication of JP2013545785A publication Critical patent/JP2013545785A/ja
Publication of JP2013545785A5 publication Critical patent/JP2013545785A5/ja
Application granted granted Critical
Publication of JP6005656B2 publication Critical patent/JP6005656B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013543799A 2010-12-16 2011-12-16 ベンゾイミダゾール呼吸合胞体ウイルス阻害剤 Expired - Fee Related JP6005656B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10195467.5 2010-12-16
EP10195467 2010-12-16
PCT/EP2011/073008 WO2012080446A1 (en) 2010-12-16 2011-12-16 Benzimidazole respiratory syncytial virus inhibitors

Publications (3)

Publication Number Publication Date
JP2013545785A JP2013545785A (ja) 2013-12-26
JP2013545785A5 true JP2013545785A5 (https=) 2014-06-26
JP6005656B2 JP6005656B2 (ja) 2016-10-12

Family

ID=43875271

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013543799A Expired - Fee Related JP6005656B2 (ja) 2010-12-16 2011-12-16 ベンゾイミダゾール呼吸合胞体ウイルス阻害剤

Country Status (30)

Country Link
US (1) US8865705B2 (https=)
EP (1) EP2651903B1 (https=)
JP (1) JP6005656B2 (https=)
KR (1) KR101876240B1 (https=)
CN (2) CN103313974A (https=)
AR (1) AR085203A1 (https=)
AU (1) AU2011343255B2 (https=)
BR (1) BR112013012137A2 (https=)
CA (1) CA2821999C (https=)
CL (1) CL2013001713A1 (https=)
CY (1) CY1117751T1 (https=)
DK (1) DK2651903T3 (https=)
EA (1) EA022972B1 (https=)
ES (1) ES2576180T3 (https=)
HK (1) HK1247616A1 (https=)
HR (1) HRP20160650T1 (https=)
HU (1) HUE029247T2 (https=)
IL (1) IL225640A (https=)
MX (1) MX340030B (https=)
MY (1) MY156641A (https=)
NZ (1) NZ609450A (https=)
PH (1) PH12013500796A1 (https=)
PL (1) PL2651903T3 (https=)
PT (1) PT2651903E (https=)
SG (1) SG190766A1 (https=)
SI (1) SI2651903T1 (https=)
TW (1) TWI530495B (https=)
UA (1) UA112298C2 (https=)
WO (1) WO2012080446A1 (https=)
ZA (1) ZA201304424B (https=)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI501967B (zh) 2010-12-16 2015-10-01 Janssen R&D Ireland 作為呼吸道融合病毒抗病毒劑之氮雜吲哚類
TWI541241B (zh) 2010-12-16 2016-07-11 健生科學愛爾蘭無限公司 作為呼吸道融合病毒抗病毒劑之咪唑并吡啶類
TWI527814B (zh) * 2010-12-16 2016-04-01 健生科學愛爾蘭無限公司 作為呼吸道融合病毒抗病毒劑之氮雜苯并咪唑類
TWI530495B (zh) 2010-12-16 2016-04-21 健生科學愛爾蘭無限公司 苯并咪唑呼吸道融合病毒抑制劑
TWI515187B (zh) * 2010-12-16 2016-01-01 健生科學愛爾蘭無限公司 作為呼吸道融合病毒抗病毒劑之吲哚類
LT2864323T (lt) * 2012-06-15 2017-07-25 Janssen Sciences Ireland Uc 1,3-dihidro-2h-benzimidazol-2-ono dariniai, turintys heterociklų pakaitų, kaip antivirusiniai agentai prieš respiratorinį sincitinį virusą
WO2013186334A1 (en) * 2012-06-15 2013-12-19 Janssen R&D Ireland 1,3-dihydro-2h-benzimidazol-2-one derivatives substituted with benzimidazoles as respiratory syncytial virus antiviral agents
RU2015102792A (ru) * 2012-07-10 2016-08-27 Ф. Хоффманн-Ля Рош Аг Новые индазолы для лечения и профилактики респираторно-синцитиальной вирусной инфекции
BR112015008325B1 (pt) * 2012-10-16 2022-01-25 Janssen Sciences Ireland Uc Compostos antivirais contra o rsv, seu uso e composição farmacêutica que os compreende
CA2895430C (en) 2013-01-28 2021-11-23 Janssen Sciences Ireland Uc Quinoxalinones and dihydroquinoxalinones as respiratory syncytial virus antiviral agents
EP2997028A1 (en) 2013-05-14 2016-03-23 F.Hoffmann-La Roche Ag Aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection
CN105392787B (zh) * 2013-05-14 2017-11-24 豪夫迈·罗氏有限公司 用于治疗和预防呼吸道合胞病毒感染的氮杂‑氧代‑吲哚
HK1222855A1 (zh) * 2013-08-15 2017-07-14 F. Hoffmann-La Roche Ag 新的用於治疗和预防呼吸道合胞病毒感染的氮杂-氧代-吲哚
NZ716822A (en) 2013-08-21 2017-10-27 Alios Biopharma Inc Antiviral compounds
WO2015065336A1 (en) * 2013-10-29 2015-05-07 Medivir Ab Respiratory syncytial virus inhibitors
TWI671299B (zh) 2014-04-14 2019-09-11 愛爾蘭商健生科學愛爾蘭無限公司 作為rsv抗病毒化合物之螺脲化合物
SG11201700851WA (en) * 2014-08-05 2017-03-30 Alios Biopharma Inc Combination therapy for treating a paramyxovirus
MA41614A (fr) 2015-02-25 2018-01-02 Alios Biopharma Inc Composés antiviraux
MY197231A (en) 2015-07-22 2023-06-06 Enanta Pharm Inc Benzodiazepine derivatives as rsv inhibitors
CN108699077B (zh) 2016-01-15 2021-03-02 英安塔制药有限公司 作为rsv抑制剂的杂环化合物
AU2018221820B2 (en) 2017-02-16 2023-11-02 Enanta Pharmaceuticals, Inc. Processes for the preparation of benzodiazepine derivatives
WO2019006295A1 (en) 2017-06-30 2019-01-03 Enanta Pharmaceuticals, Inc. HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS
CA3077309A1 (en) 2017-09-29 2019-04-04 Enanta Pharmaceuticals, Inc. Combination pharmaceutical agents as rsv inhibitors
NZ764647A (en) 2017-11-13 2025-12-19 Enanta Pharm Inc Processes for the resolution of benzodiazepin-2-one and benzoazepin-2-one derivatives
KR102926658B1 (ko) 2019-03-18 2026-02-11 이난타 파마슈티칼스, 인코포레이티드 Rsv 억제제로서의 벤조디아제핀 유도체
US11505558B1 (en) 2019-10-04 2022-11-22 Enanta Pharmaceuticals, Inc. Antiviral heterocyclic compounds
AU2020357452B2 (en) 2019-10-04 2026-01-29 Enanta Pharmaceuticals, Inc Antiviral heterocyclic compounds
UY39032A (es) 2020-01-24 2021-07-30 Enanta Pharm Inc Compuestos heterocíclicos como agentes antivirales
JP2023528969A (ja) 2020-06-11 2023-07-06 ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー 3-({5-クロロ-1-[3-(メチルスルホニル)プロピル]-1H-インドール-2 イル}メチル)-1-(2,2,2-トリフルオロエチル)-1,3-ジヒドロ-2H-イミダゾ[4,5-c]ピリジン-2-オンのヘミ(L)-酒石酸塩形態及びそれを含む医薬組成物
US11534439B2 (en) 2020-07-07 2022-12-27 Enanta Pharmaceuticals, Inc. Dihydroquinoxaline and dihydropyridopyrazine derivatives as RSV inhibitors
US11945824B2 (en) 2020-10-19 2024-04-02 Enanta Pharmaceuticals, Inc. Heterocyclic compounds as anti-viral agents
IL305189A (en) 2021-02-26 2023-10-01 Enanta Pharm Inc Heterocyclic antiviral compounds
AR129003A1 (es) 2022-04-07 2024-07-03 Enanta Pharm Inc Compuestos heterocíclicos antivirales
US12162857B2 (en) 2022-04-27 2024-12-10 Enanta Pharmaceuticals, Inc. Antiviral compounds
WO2024174953A1 (zh) * 2023-02-21 2024-08-29 苏州隆博泰药业有限公司 苯并咪唑类衍生物及其医药用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002514162A (ja) 1996-07-08 2002-05-14 デュポン ファーマシューティカルズ カンパニー Xa因子阻害薬およびトロンビン阻害薬としてのアミジノインドール類、アミジノアゾール類、およびそれらの類似体
WO2000020400A1 (en) 1998-10-05 2000-04-13 Axys Pharmaceuticals, Inc. Novel compounds and compositions for treating hepatitis c infections
SG122814A1 (en) 1999-06-28 2006-06-29 Janssen Pharmaceutica Nv Respiratory syncytial virus replication inhibitors
EA005027B1 (ru) 1999-06-28 2004-10-28 Янссен Фармацевтика Н.В. Ингибиторы репликации респираторно-синцитиального вируса
AU6762400A (en) 1999-08-12 2001-03-13 Cor Therapeutics, Inc. Inhibitors of factor xa
US6489338B2 (en) * 2000-06-13 2002-12-03 Bristol-Myers Squibb Company Imidazopyridine and imidazopyrimidine antiviral agents
US6506738B1 (en) 2000-09-27 2003-01-14 Bristol-Myers Squibb Company Benzimidazolone antiviral agents
US6919331B2 (en) * 2001-12-10 2005-07-19 Bristol-Myers Squibb Company Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents
US20040166137A1 (en) 2002-11-08 2004-08-26 Lackey John William Hetero-substituted benzimidazole compounds and antiviral uses thereof
TWI515187B (zh) 2010-12-16 2016-01-01 健生科學愛爾蘭無限公司 作為呼吸道融合病毒抗病毒劑之吲哚類
TWI501967B (zh) 2010-12-16 2015-10-01 Janssen R&D Ireland 作為呼吸道融合病毒抗病毒劑之氮雜吲哚類
TWI530495B (zh) 2010-12-16 2016-04-21 健生科學愛爾蘭無限公司 苯并咪唑呼吸道融合病毒抑制劑
TWI541241B (zh) 2010-12-16 2016-07-11 健生科學愛爾蘭無限公司 作為呼吸道融合病毒抗病毒劑之咪唑并吡啶類
TWI527814B (zh) 2010-12-16 2016-04-01 健生科學愛爾蘭無限公司 作為呼吸道融合病毒抗病毒劑之氮雜苯并咪唑類

Similar Documents

Publication Publication Date Title
JP2013545785A5 (https=)
JP2014503525A5 (https=)
RU2477723C2 (ru) Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе
JP2015505296A5 (https=)
JP2016523955A5 (https=)
JP2014511892A5 (https=)
JP2015537020A5 (https=)
JP2014506907A5 (https=)
JP2014507455A5 (https=)
JP2017504635A5 (https=)
JP2012092103A5 (https=)
JP2013510120A5 (https=)
JP2016503793A5 (https=)
JP2014500861A5 (https=)
JP2010523522A5 (https=)
JP2016515560A5 (https=)
JP2016518437A5 (https=)
JP2013032389A5 (https=)
JP2016513130A5 (https=)
JP2013537203A5 (https=)
JP2014511891A5 (https=)
JP2013534248A5 (https=)
JP2013542261A5 (https=)
JP2019516739A5 (https=)
EP2607363A4 (en) CONDENSED RING COMPOUND FOR USE AS MINERALOCORTICOID RECEPTOR ANTAGONISTS